Jiebai-Qingfei San Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Modulating Inflammation, Oxidative Stress, and Macrophage-Associated Phenotypes
Background: Jiebai-Qingfei San (JBQFS) is a seven-herb traditional Chinese veterinary formulation developed for respiratory disorders. However, its pharmacological effects against acute pulmonary inflammation and the associated molecular responses remain unclear. This study examined the protective activity of JBQFS in LPS-induced acute lung injury (ALI) and characterized the biological responses associated with treatment. Methods: The chemical profile of JBQFS was characterized by ultra-high-performance liquid chromatography coupled with high-resolution tandem mass spectrometry (UHPLC-HRMS/MS), and two representative marker compounds were quantified by high-performance liquid chromatography (HPLC). Lung transcriptomic analysis followed by qRT-PCR validation was performed to identify inflammation-related transcriptional responses. The effects of JBQFS were further examined in the murine alveolar macrophage cell line MH-S following LPS stimulation. Results: JBQFS pretreatment ameliorated LPS-induced alterations in respiratory parameters and attenuated histopathological injury, reduced inflammatory cytokine levels, and improved oxidative stress-related parameters. It also modulated macrophage-associated markers in lung tissue. Transcriptomic and qRT-PCR analyses showed that JBQFS administration was associated with changes in inflammation-related transcriptional responses, including genes related to TLR4/MyD88/NF-κB signaling. In MH-S cells, JBQFS reduced inflammatory mediator production and intracellular ROS and Ca2+ levels, preserved mitochondrial membrane potential, and modulated CD80, CD86, and CD206 expression. Conclusions: Pretreatment with JBQFS protected against LPS-induced ALI and was associated with reduced inflammation and oxidative stress, as well as modulation of macrophage-associated inflammatory phenotypes. These findings support further investigation of JBQFS for inflammatory respiratory disorders.
Authors
- 虞亚明
- Xiangwen Deng
- Yang Yang (ORCID: https://orcid.org/0009-0008-3667-4599)
- Kexin Fang (ORCID: https://orcid.org/0009-0009-9996-4697)
- Deyun Wang
- Jin He
- Lin Yu
Institutions
- Nanjing Agricultural University (CN)
- Fujian Agriculture and Forestry University (CN)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/ph19111835
- Primary Topic
- Traditional Chinese Medicine Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities